Investors on the quest for market-beating returns often employ the strategy of stock picking. Making informed choices in stocks can greatly amplify your wealth.
The closing price of Oncolytics Biotech, Inc (NASDAQ: ONCY) was $0.75 for the day, down -2.98% from the previous closing price of $0.77. In other words, the price has decreased by -$2.98 from its previous closing price. On the day, 1.03 million shares were traded. ONCY stock price reached its highest trading level at $0.81 during the session, while it also had its lowest trading level at $0.7412.
Ratios:
Our analysis of ONCY’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 3.21 and its Current Ratio is at 3.21. In the meantime, Its Debt-to-Equity ratio is 0.15 whereas as Long-Term Debt/Eq ratio is at 0.11.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Maxim Group on October 06, 2022, initiated with a Buy rating and assigned the stock a target price of $3.
On February 17, 2021, H.C. Wainwright started tracking the stock assigning a Buy rating and target price of $15.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ONCY now has a Market Capitalization of 67508928 and an Enterprise Value of 54356592.
Stock Price History:
The Beta on a monthly basis for ONCY is 1.07, which has changed by -0.25742573 over the last 52 weeks, in comparison to a change of 0.11937654 over the same period for the S&P500. Over the past 52 weeks, ONCY has reached a high of $1.53, while it has fallen to a 52-week low of $0.33. The 50-Day Moving Average of the stock is 41.08%, while the 200-Day Moving Average is calculated to be -3.89%.
Shares Statistics:
ONCY traded an average of 772.05K shares per day over the past three months and 1071060 shares per day over the past ten days. A total of 86.42M shares are outstanding, with a floating share count of 85.98M. Insiders hold about 3.20% of the company’s shares, while institutions hold 10.75% stake in the company. Shares short for ONCY as of 1749772800 were 2605451 with a Short Ratio of 3.37, compared to 1747267200 on 2234608. Therefore, it implies a Short% of Shares Outstanding of 2605451 and a Short% of Float of 3.05.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
Earnings Estimates
The current rating of Oncolytics Biotech, Inc (ONCY) reflects the combined expertise of 3.0 analysts actively engaged in assessing its market performance.The consensus estimate for the next quarter is -$0.09, with high estimates of -$0.08 and low estimates of -$0.1.
Analysts are recommending an EPS of between -$0.31 and -$0.39 for the fiscal current year, implying an average EPS of -$0.35. EPS for the following year is -$0.38, with 3.0 analysts recommending between -$0.33 and -$0.42.
